The Weekly Dose 5.6.25

Compound Tirzepatide Lawsuit + Meaningful PBM Reform!

This one is packed, y’all.

In this week’s episode of The Weekly Dose, I broke down the latest developments in the ongoing lawsuit between the Outsourcing Facilities Association and the FDA over compounded tirzepatide. A lot of people saw the dismissal of the OFA’s appeal and thought it meant the case was over. It is not. That was just a formality. The actual ruling on whether the FDA’s decision to remove tirzepatide from the shortage list holds up is still coming, and it could land any day now. I explain what happened, what is next, and why it matters for those of us depending on compounded GLP-1 meds for access.

I also covered a huge win right here in Iowa that deserves more attention. The state legislature just passed a bill that finally starts to rein in the unchecked power of Pharmacy Benefit Managers. This is the first real attempt in years to force transparency and accountability from the middlemen who decide which drugs we get, how much they cost, and whether our pharmacy gets paid at all. I explained how this could lay the groundwork for other states to follow and why people on GLP-1s should care.

We also dug into the CVS Caremark news. If you are on Zepbound and your insurance runs through CVS, they are switching their formulary in July to favor Wegovy. It is a backdoor deal with Novo Nordisk and it could push tens of thousands of patients off a dual agonist that is actually working for them. I gave step by step advice for how to protect your access and work with your doctor to stay on the medication that is right for you.

And while all this was happening, something wild happened on Substack.

In just ten days, On The Pen is now ranked number fifteen in the health and wellness category. That is wild. If fifteen more people sign up as paid subscribers, we will hit the best sellers list. That would be a huge boost for this movement and would push our platform in front of tens of thousands of new readers. It would also be a big step toward my goal of hitting top ten podcast and top ten Substack before my fortieth birthday next month. I have never said this before but I am saying it now. I believe we can do this. We are building something real.

🎧 The full podcast is embedded below. Give it a listen and share it if it resonates.

👇 All links, including Substack, YouTube, TikTok, podcast apps, and our forum, are right here:
https://linktr.ee/manonthemounjaro

If you have been on the fence about going paid, this is the moment. Your support does not just unlock deeper dives and insider content. It helps build the first patient centered news outlet focused on GLP-1 medications. And that means everything to me.

What part of this week’s episode hit hardest for you? Let’s talk in the comments.